Pathobiology of acute and chronic hepatitis B virus infection: an introduction

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.

Human vaccines & immunotherapeutics·2019

The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease.

Gut·2006

Relation between viral fitness and immune escape within the hepatitis C virus protease.

Gut·2005

Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate.

Vaccine·2001

Flow cytometric determination of cytokine production and proliferation in hepatitis B core antigen specific murine CD4 cells: lack of correlation between number of cytokine producing cells and cytokine levels in supernatant.

Journal of immunological methods·2001

Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice.

Antiviral research·2001

Development of a Machine Learning Model to Predict Short Duration HCV Treatment Response.

Journal of viral hepatitis·2026

Progress Towards Eliminating Hepatitis C as a Public Health Threat in Norway.

Journal of viral hepatitis·2026

A Novel Quantitative ELISA Demonstrates Lack of Correlation Between Serum HDV-RNA and Anti-HDV Antibody Levels in Chronic HDV Infection.

Journal of viral hepatitis·2026

ALG-020572, an Antisense Oligonucleotide for the Treatment of Chronic Hepatitis B Virus Infection Discontinued for Drug-Induced Liver Injury.

Journal of viral hepatitis·2026

Virologic Response to Antiviral Therapy in Chronic Hepatitis B Patients With High Viral Load: A Real-World Cohort Study.

Journal of viral hepatitis·2026

Peripheral Biomarkers in Chronic Hepatitis D Infection: A Review.

Journal of viral hepatitis·2026

High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.

Journal of human immunity·2026

Gut microbiota functional remodeling and butyrate depletion amplify anti-Ro/La antibody-driven type I interferon activation in neonatal lupus.

Gut microbes·2026

Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.

International reviews of immunology·2026

Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

Somatic Hypermutations Enhance Neutralization Breadth of IGHV3-53/3-66 Public Antibodies Against SARS-CoV-2 Variants.

Immunity, inflammation and disease·2026

Inferior vena cava agenesis: Clinical presentation, imaging characteristics, and midterm outcomes with a proposed diagnostic algorithm.

Phlebology·2026

Related Experiment Videos

Pathobiology of acute and chronic hepatitis B virus infection: an introduction

Related Concept Videos

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.

The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease.

Relation between viral fitness and immune escape within the hepatitis C virus protease.

Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate.

Flow cytometric determination of cytokine production and proliferation in hepatitis B core antigen specific murine CD4 cells: lack of correlation between number of cytokine producing cells and cytokine levels in supernatant.

Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice.

Development of a Machine Learning Model to Predict Short Duration HCV Treatment Response.

Progress Towards Eliminating Hepatitis C as a Public Health Threat in Norway.

A Novel Quantitative ELISA Demonstrates Lack of Correlation Between Serum HDV-RNA and Anti-HDV Antibody Levels in Chronic HDV Infection.

ALG-020572, an Antisense Oligonucleotide for the Treatment of Chronic Hepatitis B Virus Infection Discontinued for Drug-Induced Liver Injury.

Virologic Response to Antiviral Therapy in Chronic Hepatitis B Patients With High Viral Load: A Real-World Cohort Study.

Peripheral Biomarkers in Chronic Hepatitis D Infection: A Review.

High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.

Gut microbiota functional remodeling and butyrate depletion amplify anti-Ro/La antibody-driven type I interferon activation in neonatal lupus.

Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.

Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.

Somatic Hypermutations Enhance Neutralization Breadth of IGHV3-53/3-66 Public Antibodies Against SARS-CoV-2 Variants.

Inferior vena cava agenesis: Clinical presentation, imaging characteristics, and midterm outcomes with a proposed diagnostic algorithm.

Related Experiment Videos

Pathobiology of acute and chronic hepatitis B virus infection: an introduction

Related Concept Videos

Related Articles